New hope for advanced breast cancer patients in First-Ever drug trial
Disease control
Recruiting now
This is the first human study testing a new oral medication called RGT-419B for people with advanced breast cancer that has stopped responding to standard treatments. The trial will enroll 64 adults to determine if the drug is safe and tolerable when taken alone or combined with …
Phase: PHASE1 • Sponsor: Regor Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC